Table 3.
Analysis of risk factors affecting LA clearance rate in patients
| Variable | Total | <10% (n=65) | ≥10% (n=453) | Statistic | P-Value |
|---|---|---|---|---|---|
| Age (years) | 65.00 [60.00, 70.00] | 65.00 [59.00, 70.00] | 69.00 [64.00, 78.00] | 5.345 | <0.001 |
| Gender | |||||
| Male | 384 (74.13%) | 337 (74.39%) | 47 (72.31%) | 0.129 | 0.720 |
| Female | 134 (25.87%) | 116 (25.61%) | 18 (27.69%) | ||
| BMI (kg/m2) | 24.20 [21.98, 25.99] | 24.21 [21.75, 26.00] | 24.12 [22.82, 25.85] | 0.543 | 0.587 |
| Cancer Type | |||||
| Gastric Cancer | 305 (58.88%) | 262 (57.84%) | 43 (66.15%) | 1.922 | 0.382 |
| Esophageal Cancer | 185 (35.71%) | 165 (36.42%) | 20 (30.77%) | ||
| Other | 28 (5.41%) | 26 (5.74%) | 2 (3.08%) | ||
| TNM Stage | |||||
| Stage II | 56 (10.81%) | 48 (10.60%) | 8 (12.31%) | 0.787 | 0.675 |
| Stage III | 134 (25.87%) | 120 (26.49%) | 14 (21.54%) | ||
| Stage IV | 328 (63.32%) | 285 (62.91%) | 43 (66.15%) | ||
| 24 h Blood Loss | |||||
| ≥1000 mL | 105 (20.27%) | 83 (18.32%) | 22 (33.85%) | 8.476 | 0.004 |
| <1000 mL | 413 (79.73%) | 370 (81.68%) | 43 (66.15%) | ||
| 24 h Blood Transfusion | |||||
| Yes | 281 (54.25%) | 244 (53.86%) | 37 (56.92%) | 0.214 | 0.643 |
| No | 237 (45.75%) | 209 (46.14%) | 28 (43.08%) | ||
| Time from Bleeding to Admission | |||||
| ≥12 h | 315 (60.81%) | 267 (58.94%) | 48 (73.85%) | 5.300 | 0.021 |
| <12 h | 203 (39.19%) | 186 (41.06%) | 17 (26.15%) | ||
| Hemorrhagic Shock | |||||
| Yes | 134 (25.87%) | 110 (24.28%) | 24 (36.92%) | 4.736 | 0.030 |
| No | 384 (74.13%) | 343 (75.72%) | 41 (63.08%) | ||
| Received Radiation/Chemotherapy | |||||
| Yes | 346 (66.80%) | 301 (66.45%) | 45 (69.23%) | 0.199 | 0.656 |
| No | 172 (33.20%) | 152 (33.55%) | 20 (30.77%) | ||
| Diabetes History | |||||
| Yes | 104 (20.08%) | 94 (20.75%) | 10 (15.38%) | 1.020 | 0.313 |
| No | 414 (79.92%) | 359 (79.25%) | 55 (84.62%) | ||
| Hypertension History | |||||
| Yes | 187 (36.10%) | 163 (35.98%) | 24 (36.92%) | 0.022 | 0.883 |
| No | 331 (63.90%) | 290 (64.02%) | 41 (63.08%) | ||
| Hemostasis Method | |||||
| Interventional Embolization | 333 (64.29%) | 45 (69.23%) | 288 (63.58%) | 0.792 | 0.374 |
| Endoscopic Hemostasis | 185 (35.71%) | 20 (30.77%) | 165 (36.42%) | ||
| Fluid Resuscitation Plan | |||||
| IV | 301 (58.11%) | 252 (55.63%) | 49 (75.38%) | 9.114 | 0.003 |
| IO | 217 (41.89%) | 201 (44.37%) | 16 (24.62%) | ||
| First Cannulation Success Rate | |||||
| Success | 444 (85.71%) | 389 (85.87%) | 55 (84.62%) | 0.073 | 0.787 |
| Failure | 74 (14.29%) | 64 (14.13%) | 10 (15.38%) | ||
| Resuscitation Success Rate | |||||
| Success | 483 (93.24%) | 424 (93.60%) | 59 (90.77%) | 0.722 | 0.395 |
| Failure | 35 (6.76%) | 29 (6.40%) | 6 (9.23%) | ||
| Time of Venous Access Establishment (min) | 4.50 [2.00, 6.00] | 4.00 [2.00, 6.00] | 5.00 [4.00, 6.00] | 1.327 | 0.185 |
| Time to Blood Pressure Recovery After Fluid Resuscitation (min) | 11.00 [9.00, 12.00] | 11.00 [9.00, 12.00] | 12.00 [10.00, 13.00] | 2.254 | 0.024 |
| Infusion Rate (mL/min) | 15.00 [13.00, 17.00] | 15.00 [13.00, 17.00] | 15.00 [13.00, 17.00] | 0.798 | 0.425 |
| Urine Output (mL) | 84.04±24.19 | 84.14±24.39 | 83.40±22.96 | 0.229 | 0.819 |
| Pre-fluid ALB (g/L) | 59.91±10.16 | 59.99±10.21 | 59.37±9.83 | 0.461 | 0.645 |
| 6 h Post-fluid ALB (g/L) | 126.00 [114.00, 138.00] | 127.00 [114.00, 139.00] | 121.00 [110.00, 133.00] | 1.651 | 0.099 |